Ategra Capital Management, LLC Novartis Ag Transaction History

Ategra Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Feb 13, 2025	SELL	$92.57 - $107.37 $364,077 - $422,286	-3,933 Closed	0 $0
Q3 2023 Feb 13, 2025	SELL	$94.73 - $105.13 $5,494 - $6,097	-58 Reduced 1.45%	3,933 $401 Million
Q2 2022 Feb 13, 2025	SELL	$80.52 - $93.75 $18,519 - $21,562	-230 Reduced 5.45%	3,991 $337 Million
Q1 2022 Feb 13, 2025	SELL	$80.11 - $90.62 $38,933 - $44,041	-486 Reduced 10.33%	4,221 $370 Million
Q4 2021 Feb 13, 2025	SELL	$79.7 - $88.13 $19,526 - $21,591	-245 Reduced 4.95%	4,707 $412 Million
Q3 2021 Feb 13, 2025	SELL	$81.78 - $95.14 $18,972 - $22,072	-232 Reduced 4.48%	4,952 $405 Million
Q2 2021 Feb 13, 2025	BUY	$85.24 - $94.15 $13,382 - $14,781	157 Added 3.12%	5,184 $473 Million
Q2 2020 Feb 13, 2025	BUY	$80.93 - $91.1 $1,052 - $1,184	13 Added 0.26%	5,027 $439 Million
Q1 2020 Feb 13, 2025	BUY	$70.67 - $99.01 $8,692 - $12,178	123 Added 2.51%	5,014 $413 Million
Q3 2019 Feb 13, 2025	SELL	$85.54 - $94.26 $5,303 - $5,844	-62 Reduced 1.25%	4,891 $425 Million
Q1 2019 Feb 13, 2025	BUY	$75.32 - $86.15 $373,059 - $426,700	4,953 New	4,953 $476 Million

1,472

134M

1.31M

1.56M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ategra Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ategra Capital Management, LLC with notifications on news.